In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...
reside in bone marrow and continuously produce a variety of blood and immune system cells. Mesenchymal stem cells are the source of new bone, cartilage, and connective tissue cells. Neuronal stem ...
Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate ...
A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science ...
FDA gives nod of approval to first derived mesenchymal stromal cell therapy for the treatment of pediatric patients with ...
Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...
The Company’s novel approach using autologous mesenchymal stem cells to alleviate the disease-caused damage in diabetics offers a new hope to address the sufferings in diabetes patients without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback